{"id": "article-25198_0", "title": "Mitral Regurgitation -- Continuing Education Activity", "content": "Mitral regurgitation\u00a0is a heart condition characterized by the incomplete closure of the mitral valve, leading to the backflow of blood from the left ventricle into the left atrium during systole. This results in a systolic murmur heard at the apex of the heart, often radiating to the left axilla. With a global prevalence of over 2%, mitral regurgitation is a common valvular abnormality with various causes, including congenital conditions, rheumatic fever, and degenerative changes in the valve. This overview aims to cover the essentials of mitral regurgitation, from its pathophysiology and etiology to its evaluation and management, underscoring the importance of early detection and appropriate intervention for optimal patient outcomes.", "contents": "Mitral Regurgitation -- Continuing Education Activity. Mitral regurgitation\u00a0is a heart condition characterized by the incomplete closure of the mitral valve, leading to the backflow of blood from the left ventricle into the left atrium during systole. This results in a systolic murmur heard at the apex of the heart, often radiating to the left axilla. With a global prevalence of over 2%, mitral regurgitation is a common valvular abnormality with various causes, including congenital conditions, rheumatic fever, and degenerative changes in the valve. This overview aims to cover the essentials of mitral regurgitation, from its pathophysiology and etiology to its evaluation and management, underscoring the importance of early detection and appropriate intervention for optimal patient outcomes."}
{"id": "article-25198_1", "title": "Mitral Regurgitation -- Continuing Education Activity", "content": "By participating in this course, learners comprehensively understand mitral regurgitation, including its clinical features, diagnostic modalities, and therapeutic options. Collaborating with an interprofessional team, including cardiologists, cardiac surgeons, nurses, and imaging specialists, enhances patient outcomes by facilitating a multidisciplinary approach to care. Through shared expertise and coordinated efforts, clinicians can accurately diagnose mitral regurgitation, tailor treatment plans to individual patient needs, and optimize post-intervention care for improved long-term outcomes.\u00a0Interdisciplinary collaboration ensures that patients receive holistic care addressing the valvular abnormality, comorbidities, and psychosocial factors, ultimately promoting a better quality of life and overall cardiac health.", "contents": "Mitral Regurgitation -- Continuing Education Activity. By participating in this course, learners comprehensively understand mitral regurgitation, including its clinical features, diagnostic modalities, and therapeutic options. Collaborating with an interprofessional team, including cardiologists, cardiac surgeons, nurses, and imaging specialists, enhances patient outcomes by facilitating a multidisciplinary approach to care. Through shared expertise and coordinated efforts, clinicians can accurately diagnose mitral regurgitation, tailor treatment plans to individual patient needs, and optimize post-intervention care for improved long-term outcomes.\u00a0Interdisciplinary collaboration ensures that patients receive holistic care addressing the valvular abnormality, comorbidities, and psychosocial factors, ultimately promoting a better quality of life and overall cardiac health."}
{"id": "article-25198_2", "title": "Mitral Regurgitation -- Continuing Education Activity", "content": "Objectives: Differentiate between primary and secondary mitral regurgitation etiologies, utilizing diagnostic imaging and echocardiography to distinguish structural abnormalities from functional changes in the mitral valve. Screen patients with signs of heart failure or valvular heart disease for potential mitral regurgitation, incorporating comprehensive history-taking and physical examination techniques to assess risk factors and identify at-risk populations. Implement evidence-based treatment protocols for managing mitral regurgitation, including pharmacological interventions, lifestyle modifications, and surgical or transcatheter interventions, to optimize patient outcomes and prevent disease progression. Collaborate with an interprofessional healthcare team to develop comprehensive care plans tailored to each patient's unique needs, integrating input from specialists and allied health professionals to optimize treatment outcomes and improve patient satisfaction. Access free multiple choice questions on this topic.", "contents": "Mitral Regurgitation -- Continuing Education Activity. Objectives: Differentiate between primary and secondary mitral regurgitation etiologies, utilizing diagnostic imaging and echocardiography to distinguish structural abnormalities from functional changes in the mitral valve. Screen patients with signs of heart failure or valvular heart disease for potential mitral regurgitation, incorporating comprehensive history-taking and physical examination techniques to assess risk factors and identify at-risk populations. Implement evidence-based treatment protocols for managing mitral regurgitation, including pharmacological interventions, lifestyle modifications, and surgical or transcatheter interventions, to optimize patient outcomes and prevent disease progression. Collaborate with an interprofessional healthcare team to develop comprehensive care plans tailored to each patient's unique needs, integrating input from specialists and allied health professionals to optimize treatment outcomes and improve patient satisfaction. Access free multiple choice questions on this topic."}
{"id": "article-25198_3", "title": "Mitral Regurgitation -- Introduction", "content": "Mitral regurgitation (MR) is the most common valvular abnormality worldwide, affecting over 2% of the total population, and has a prevalence that\u00a0increases with age. [1] [2] [3] MR is the retrograde flow of blood from the left ventricle (LV) into the left atrium (LA) through the mitral valve (MV), causing a systolic murmur heard best at the apex of the heart with the sound radiating to the left axilla (see Image. Mitral Regurgitation During Systole).", "contents": "Mitral Regurgitation -- Introduction. Mitral regurgitation (MR) is the most common valvular abnormality worldwide, affecting over 2% of the total population, and has a prevalence that\u00a0increases with age. [1] [2] [3] MR is the retrograde flow of blood from the left ventricle (LV) into the left atrium (LA) through the mitral valve (MV), causing a systolic murmur heard best at the apex of the heart with the sound radiating to the left axilla (see Image. Mitral Regurgitation During Systole)."}
{"id": "article-25198_4", "title": "Mitral Regurgitation -- Introduction -- Anatomy of Mitral Valve", "content": "The mitral valve consists of\u00a02 leaflets (anterior and posterior) sitting within the annulus. The posterior mitral leaflet originates from the LA endocardium. The leaflets\u00a0are supported\u00a0by a subvalvular apparatus comprising 2 papillary muscles (anterolateral and posteromedial) that arise from the LV myocardium and the chordae tendineae. [4] [5]", "contents": "Mitral Regurgitation -- Introduction -- Anatomy of Mitral Valve. The mitral valve consists of\u00a02 leaflets (anterior and posterior) sitting within the annulus. The posterior mitral leaflet originates from the LA endocardium. The leaflets\u00a0are supported\u00a0by a subvalvular apparatus comprising 2 papillary muscles (anterolateral and posteromedial) that arise from the LV myocardium and the chordae tendineae. [4] [5]"}
{"id": "article-25198_5", "title": "Mitral Regurgitation -- Introduction -- Types of Mitral Regurgitation", "content": "Mitral regurgitation\u00a0is subdivided\u00a0into primary and secondary . [6]", "contents": "Mitral Regurgitation -- Introduction -- Types of Mitral Regurgitation. Mitral regurgitation\u00a0is subdivided\u00a0into primary and secondary . [6]"}
{"id": "article-25198_6", "title": "Mitral Regurgitation -- Introduction -- Primary mitral regurgitation", "content": "Also called degenerative or\u00a0organic Resulting from the structural deformity of or damage to the leaflets, chordae, or\u00a0papillary muscles, causing leaflets to close insufficiently during\u00a0systole Common causes: papillary muscle rupture, mitral valve prolapse (MVP), or leaflet perforation [5]", "contents": "Mitral Regurgitation -- Introduction -- Primary mitral regurgitation. Also called degenerative or\u00a0organic Resulting from the structural deformity of or damage to the leaflets, chordae, or\u00a0papillary muscles, causing leaflets to close insufficiently during\u00a0systole Common causes: papillary muscle rupture, mitral valve prolapse (MVP), or leaflet perforation [5]"}
{"id": "article-25198_7", "title": "Mitral Regurgitation -- Introduction -- Secondary mitral regurgitation", "content": "Also called functional or\u00a0ischemic Due to left ventricular wall motion abnormalities\u00a0(ie, ischemic cardiomyopathy) or left ventricular remodeling (ie, dilated cardiomyopathy) [7] No structural problems with the valve itself [8] Leads\u00a0to mitral annular dilatation or displacement of papillary muscles, causing retrograde flow from improperly closed mitral valve leaflets The Carpentier Classification divides mitral regurgitation into\u00a03\u00a0types based on the leaflet motion:", "contents": "Mitral Regurgitation -- Introduction -- Secondary mitral regurgitation. Also called functional or\u00a0ischemic Due to left ventricular wall motion abnormalities\u00a0(ie, ischemic cardiomyopathy) or left ventricular remodeling (ie, dilated cardiomyopathy) [7] No structural problems with the valve itself [8] Leads\u00a0to mitral annular dilatation or displacement of papillary muscles, causing retrograde flow from improperly closed mitral valve leaflets The Carpentier Classification divides mitral regurgitation into\u00a03\u00a0types based on the leaflet motion:"}
{"id": "article-25198_8", "title": "Mitral Regurgitation -- Introduction", "content": "Type 1:\u00a0Normal leaflet motion Caused by annular dilation\u00a0or leaflet perforation Regurgitation jet directed centrally Type 2:\u00a0Excessive leaflet motion Caused by papillary muscle rupture, chordal rupture, or redundant chordae Eccentric jet directed away from the involved leaflet Type 3:\u00a0Restricted leaflet motion IIIa: Leaflet motion restricted in both systole and diastole Caused by\u00a0rheumatic heart disease Normal papillary muscles Jet may\u00a0be centrally or eccentrically directed IIIb: Leaflet motion restricted in\u00a0systole Caused by\u00a0papillary muscle dysfunction or left ventricular dilation Abnormal papillary muscles Jet may be centrally or eccentrically directed [3] [9] [10]", "contents": "Mitral Regurgitation -- Introduction. Type 1:\u00a0Normal leaflet motion Caused by annular dilation\u00a0or leaflet perforation Regurgitation jet directed centrally Type 2:\u00a0Excessive leaflet motion Caused by papillary muscle rupture, chordal rupture, or redundant chordae Eccentric jet directed away from the involved leaflet Type 3:\u00a0Restricted leaflet motion IIIa: Leaflet motion restricted in both systole and diastole Caused by\u00a0rheumatic heart disease Normal papillary muscles Jet may\u00a0be centrally or eccentrically directed IIIb: Leaflet motion restricted in\u00a0systole Caused by\u00a0papillary muscle dysfunction or left ventricular dilation Abnormal papillary muscles Jet may be centrally or eccentrically directed [3] [9] [10]"}
{"id": "article-25198_9", "title": "Mitral Regurgitation -- Etiology -- Primary Mitral Regurgitation", "content": "Degenerative:  The underlying pathophysiologic basis for degenerative\u00a0mitral regurgitation is most commonly related to myxomatous degeneration of the mitral valve, resulting in mitral valve prolapse (MVP). MVP can occur either as a primary, non-syndromic, or a secondary, syndromic process. In primary MVP, advancing age is the driving factor responsible for disease progression. Connective tissue diseases such as\u00a0Marfan syndrome, Ehlers-Danlos syndrome, MASS phenotype, systemic lupus\u00a0erythematosus, osteogenesis imperfecta, and pseudoxanthoma elasticum\u00a0lead to secondary MVP, causing MR. [11]", "contents": "Mitral Regurgitation -- Etiology -- Primary Mitral Regurgitation. Degenerative:  The underlying pathophysiologic basis for degenerative\u00a0mitral regurgitation is most commonly related to myxomatous degeneration of the mitral valve, resulting in mitral valve prolapse (MVP). MVP can occur either as a primary, non-syndromic, or a secondary, syndromic process. In primary MVP, advancing age is the driving factor responsible for disease progression. Connective tissue diseases such as\u00a0Marfan syndrome, Ehlers-Danlos syndrome, MASS phenotype, systemic lupus\u00a0erythematosus, osteogenesis imperfecta, and pseudoxanthoma elasticum\u00a0lead to secondary MVP, causing MR. [11]"}
{"id": "article-25198_10", "title": "Mitral Regurgitation -- Etiology -- Primary Mitral Regurgitation", "content": "Congenital: Conditions like isolated\u00a0cleft of the mitral valve, [12] double orifice mitral valve, and parachute mitral valve (PMV), which is a congenital valvular anomaly\u00a0where the chordae tendineae are attached to a single papillary muscle, have been linked to causing MR. [13] While extremely rare, these congenital conditions are well-defined in the literature as causing primary MR.", "contents": "Mitral Regurgitation -- Etiology -- Primary Mitral Regurgitation. Congenital: Conditions like isolated\u00a0cleft of the mitral valve, [12] double orifice mitral valve, and parachute mitral valve (PMV), which is a congenital valvular anomaly\u00a0where the chordae tendineae are attached to a single papillary muscle, have been linked to causing MR. [13] While extremely rare, these congenital conditions are well-defined in the literature as causing primary MR."}
{"id": "article-25198_11", "title": "Mitral Regurgitation -- Etiology -- Primary Mitral Regurgitation", "content": "Infectious/rheumatic: With an estimation of over 15 million cases worldwide, rheumatic heart disease is prevalent in developing countries due to a lack of medical resources and vaccinations. [14] Chronic rheumatic heart disease is associated with pancarditis and has mitral valve involvement, causing regurgitation in almost 100% of cases due to scarring of the valve and valve apparatus. [15] [16]", "contents": "Mitral Regurgitation -- Etiology -- Primary Mitral Regurgitation. Infectious/rheumatic: With an estimation of over 15 million cases worldwide, rheumatic heart disease is prevalent in developing countries due to a lack of medical resources and vaccinations. [14] Chronic rheumatic heart disease is associated with pancarditis and has mitral valve involvement, causing regurgitation in almost 100% of cases due to scarring of the valve and valve apparatus. [15] [16]"}
{"id": "article-25198_12", "title": "Mitral Regurgitation -- Etiology -- Secondary Mitral Regurgitation", "content": "Left ventricular dilation due to ischemic or nonischemic cardiomyopathy secondarily impairs leaflet coaptation of a structurally normal MV, resulting in secondary MR. Dysfunction and remodeling can lead to apical and lateral papillary muscle displacement, resulting in leaflet tethering, dilation, a flattening of the mitral annulus, and lower valve closing forces. [4] Reduced closing forces include\u00a0LV\u00a0contractility,\u00a0altered systolic annular contraction, reduced synchronicity between the\u00a02\u00a0papillary muscles, and global LV desynchrony, especially in basal segments.", "contents": "Mitral Regurgitation -- Etiology -- Secondary Mitral Regurgitation. Left ventricular dilation due to ischemic or nonischemic cardiomyopathy secondarily impairs leaflet coaptation of a structurally normal MV, resulting in secondary MR. Dysfunction and remodeling can lead to apical and lateral papillary muscle displacement, resulting in leaflet tethering, dilation, a flattening of the mitral annulus, and lower valve closing forces. [4] Reduced closing forces include\u00a0LV\u00a0contractility,\u00a0altered systolic annular contraction, reduced synchronicity between the\u00a02\u00a0papillary muscles, and global LV desynchrony, especially in basal segments."}
{"id": "article-25198_13", "title": "Mitral Regurgitation -- Etiology -- Secondary Mitral Regurgitation", "content": "Papillary muscle rupture: Papillary muscle rupture is\u00a0a rare\u00a0condition seen in 1% to 2% of patients after myocardial infarction (MI) or infective endocarditis that leads to severe mitral regurgitation due to dysfunction of the papillary muscles. [17] [18]", "contents": "Mitral Regurgitation -- Etiology -- Secondary Mitral Regurgitation. Papillary muscle rupture: Papillary muscle rupture is\u00a0a rare\u00a0condition seen in 1% to 2% of patients after myocardial infarction (MI) or infective endocarditis that leads to severe mitral regurgitation due to dysfunction of the papillary muscles. [17] [18]"}
{"id": "article-25198_14", "title": "Mitral Regurgitation -- Etiology -- Secondary Mitral Regurgitation", "content": "Ischemic mitral regurgitation: Ischemic mitral regurgitation  results from prior MI associated with\u00a0normal\u00a0mitral valve leaflets and chordae.\u00a0Ischemia of the segments underlying the papillary muscles results in remodeling. This phenomenon causes papillary\u00a0muscle displacement, which results in a more apical position of the leaflets, known as a\u00a0\"seagull sign.\" [19] Under Carpentier classification, the\u00a0leaflet\u00a0dysfunction\u00a0resulting\u00a0in\u00a0the\u00a0most common form of ischemic mitral regurgitation is type IIIb due to restricted motions of the leaflet(s) in systole. The degree of exercise-induced increase or decrease in MR relates to changes in LV remodeling, valvular deformation, and LV and papillary muscle synchronicity.", "contents": "Mitral Regurgitation -- Etiology -- Secondary Mitral Regurgitation. Ischemic mitral regurgitation: Ischemic mitral regurgitation  results from prior MI associated with\u00a0normal\u00a0mitral valve leaflets and chordae.\u00a0Ischemia of the segments underlying the papillary muscles results in remodeling. This phenomenon causes papillary\u00a0muscle displacement, which results in a more apical position of the leaflets, known as a\u00a0\"seagull sign.\" [19] Under Carpentier classification, the\u00a0leaflet\u00a0dysfunction\u00a0resulting\u00a0in\u00a0the\u00a0most common form of ischemic mitral regurgitation is type IIIb due to restricted motions of the leaflet(s) in systole. The degree of exercise-induced increase or decrease in MR relates to changes in LV remodeling, valvular deformation, and LV and papillary muscle synchronicity."}
{"id": "article-25198_15", "title": "Mitral Regurgitation -- Etiology -- Secondary Mitral Regurgitation", "content": "Congestive heart failure-associated: In a heart failure clinical study of 558 patients with severe congestive heart failure, defined as ejection fraction (EF) less than or equal to 35%,\u00a0MR was severe in 4.3% of the patients, moderate to severe in 12.5%, moderate in 21.9%, mild to moderate in 11.8%, mild in 39.1%, and absent or present in 10.4%. [20] This study identified the correlation between severe congestive heart failure and MR.", "contents": "Mitral Regurgitation -- Etiology -- Secondary Mitral Regurgitation. Congestive heart failure-associated: In a heart failure clinical study of 558 patients with severe congestive heart failure, defined as ejection fraction (EF) less than or equal to 35%,\u00a0MR was severe in 4.3% of the patients, moderate to severe in 12.5%, moderate in 21.9%, mild to moderate in 11.8%, mild in 39.1%, and absent or present in 10.4%. [20] This study identified the correlation between severe congestive heart failure and MR."}
{"id": "article-25198_16", "title": "Mitral Regurgitation -- Etiology -- Secondary Mitral Regurgitation", "content": "Atrial fibrillation associated: Results from a retrospective cohort study found atrial fibrillation to cause increased atrial and valve annular size, resulting in functional MR. Of the patients studied, controlling atrial fibrillation and restoring sinus rhythm resulted in an increased reduction of functional MR. [21] A randomized trial also showed that AF had an association with worsening valvular disease. [22]", "contents": "Mitral Regurgitation -- Etiology -- Secondary Mitral Regurgitation. Atrial fibrillation associated: Results from a retrospective cohort study found atrial fibrillation to cause increased atrial and valve annular size, resulting in functional MR. Of the patients studied, controlling atrial fibrillation and restoring sinus rhythm resulted in an increased reduction of functional MR. [21] A randomized trial also showed that AF had an association with worsening valvular disease. [22]"}
{"id": "article-25198_17", "title": "Mitral Regurgitation -- Etiology -- Secondary Mitral Regurgitation", "content": "Hypertrophic cardiomyopathy:\u00a0Hypertrophic cardiomyopathy (HCM) can also lead to MR. HCM\u00a0is defined\u00a0by severe left ventricular hypertrophy, which causes increased papillary muscle mass, bringing them closer together. This phenomenon causes the mitral valve leaflets to become elongated and floppy and pulls the leaflets closer to the left ventricular outflow tract, causing regurgitant\u00a0retrograde flow. [5] [23]", "contents": "Mitral Regurgitation -- Etiology -- Secondary Mitral Regurgitation. Hypertrophic cardiomyopathy:\u00a0Hypertrophic cardiomyopathy (HCM) can also lead to MR. HCM\u00a0is defined\u00a0by severe left ventricular hypertrophy, which causes increased papillary muscle mass, bringing them closer together. This phenomenon causes the mitral valve leaflets to become elongated and floppy and pulls the leaflets closer to the left ventricular outflow tract, causing regurgitant\u00a0retrograde flow. [5] [23]"}
{"id": "article-25198_18", "title": "Mitral Regurgitation -- Epidemiology", "content": "Mitral regurgitation is a common valvular abnormality occurring in about 10% of the population. [1] Mitral valve prolapse, which is related to myxomatous degeneration of the mitral valve, is the most common cause of primary mitral regurgitation. Accounting for 2% to 3% of the total population, mitral valve prolapse has been cited as the most common cardiac mitral valvular pathology\u00a0worldwide. [24] In developing countries, rheumatic heart disease remains prevalent and is the most common cause of mitral valvular pathology that results in hospital admissions. [25] [26]", "contents": "Mitral Regurgitation -- Epidemiology. Mitral regurgitation is a common valvular abnormality occurring in about 10% of the population. [1] Mitral valve prolapse, which is related to myxomatous degeneration of the mitral valve, is the most common cause of primary mitral regurgitation. Accounting for 2% to 3% of the total population, mitral valve prolapse has been cited as the most common cardiac mitral valvular pathology\u00a0worldwide. [24] In developing countries, rheumatic heart disease remains prevalent and is the most common cause of mitral valvular pathology that results in hospital admissions. [25] [26]"}
{"id": "article-25198_19", "title": "Mitral Regurgitation -- Pathophysiology", "content": "The definition of MR is a retrograde flow of blood from the LV into the left atrium LA through the MV, causing a systolic murmur heard best at the apex of the heart, with the sound radiating to the left axilla.\u00a0Mitral regurgitation leads to left ventricular volume overload due to increased stroke volume, caused by\u00a0increased\u00a0blood volume within the left atrium and an increased preload delivered to the left ventricle during diastole.", "contents": "Mitral Regurgitation -- Pathophysiology. The definition of MR is a retrograde flow of blood from the LV into the left atrium LA through the MV, causing a systolic murmur heard best at the apex of the heart, with the sound radiating to the left axilla.\u00a0Mitral regurgitation leads to left ventricular volume overload due to increased stroke volume, caused by\u00a0increased\u00a0blood volume within the left atrium and an increased preload delivered to the left ventricle during diastole."}
{"id": "article-25198_20", "title": "Mitral Regurgitation -- Pathophysiology", "content": "In\u00a0chronic progressive MR, ventricular remodeling occurs, allowing maintenance of cardiac output, and an initial increase in EF is usually observed. However, the\u00a0effective\u00a0EF can be considerably lower depending on the regurgitant fraction. Over time, there is a positive feedback loop by which volume overload from MR causes dilation of the ventricle, widening of the mitral annulus, and diminishing coaptation of leaflets, leading to progressive worsening of the MR.", "contents": "Mitral Regurgitation -- Pathophysiology. In\u00a0chronic progressive MR, ventricular remodeling occurs, allowing maintenance of cardiac output, and an initial increase in EF is usually observed. However, the\u00a0effective\u00a0EF can be considerably lower depending on the regurgitant fraction. Over time, there is a positive feedback loop by which volume overload from MR causes dilation of the ventricle, widening of the mitral annulus, and diminishing coaptation of leaflets, leading to progressive worsening of the MR."}
{"id": "article-25198_21", "title": "Mitral Regurgitation -- Pathophysiology", "content": "Eventually, volume overload becomes so severe that excitation-contraction coupling of the muscle membrane becomes impaired, and wall stress-related afterload on the left ventricle leads to dilation with decreased contractility, resulting in a reduction of EF. In addition, the regurgitant blood from the left ventricle during systole can eventually cause left atrial enlargement, impairment of left atrial contraction, and subsequent atrial fibrillation, leading to\u00a0a thrombus in the left atrial appendage. [3] [27] [28]", "contents": "Mitral Regurgitation -- Pathophysiology. Eventually, volume overload becomes so severe that excitation-contraction coupling of the muscle membrane becomes impaired, and wall stress-related afterload on the left ventricle leads to dilation with decreased contractility, resulting in a reduction of EF. In addition, the regurgitant blood from the left ventricle during systole can eventually cause left atrial enlargement, impairment of left atrial contraction, and subsequent atrial fibrillation, leading to\u00a0a thrombus in the left atrial appendage. [3] [27] [28]"}
{"id": "article-25198_22", "title": "Mitral Regurgitation -- History and Physical", "content": "Mitral valve regurgitation causes a holosystolic murmur that is heard best at the apex of the heart, with the sound radiating to the left axilla (see Video. Murmur of Mitral Regurgitation). Differentiating the murmur of mitral regurgitation from other systolic murmurs is essential. [29]", "contents": "Mitral Regurgitation -- History and Physical. Mitral valve regurgitation causes a holosystolic murmur that is heard best at the apex of the heart, with the sound radiating to the left axilla (see Video. Murmur of Mitral Regurgitation). Differentiating the murmur of mitral regurgitation from other systolic murmurs is essential. [29]"}
{"id": "article-25198_23", "title": "Mitral Regurgitation -- History and Physical", "content": "Mitral valve prolapse: an early systolic murmur heard best at the cardiac apex but with\u00a0a mid-systolic click", "contents": "Mitral Regurgitation -- History and Physical. Mitral valve prolapse: an early systolic murmur heard best at the cardiac apex but with\u00a0a mid-systolic click"}
{"id": "article-25198_24", "title": "Mitral Regurgitation -- History and Physical", "content": "Tricuspid regurgitation: a high-pitched, blowing, holosystolic murmur heard best at the lower left sternal border, with radiation\u00a0to the right lower sternal border; increases with inspiration", "contents": "Mitral Regurgitation -- History and Physical. Tricuspid regurgitation: a high-pitched, blowing, holosystolic murmur heard best at the lower left sternal border, with radiation\u00a0to the right lower sternal border; increases with inspiration"}
{"id": "article-25198_25", "title": "Mitral Regurgitation -- History and Physical", "content": "Ventral septal defect: a holosystolic murmur (The more significant the ventral septal defect, the quieter the murmur.)", "contents": "Mitral Regurgitation -- History and Physical. Ventral septal defect: a holosystolic murmur (The more significant the ventral septal defect, the quieter the murmur.)"}
{"id": "article-25198_26", "title": "Mitral Regurgitation -- History and Physical", "content": "Aortic stenosis: a mid-systolic,\u00a0crescendo-decrescendo murmur with radiation toward the neck; gets quieter with Valsalva maneuver or\u00a0standing", "contents": "Mitral Regurgitation -- History and Physical. Aortic stenosis: a mid-systolic,\u00a0crescendo-decrescendo murmur with radiation toward the neck; gets quieter with Valsalva maneuver or\u00a0standing"}
{"id": "article-25198_27", "title": "Mitral Regurgitation -- History and Physical", "content": "Pulmonic stenosis: mid-systolic,\u00a0crescendo-decrescendo murmur, increases in intensity during inspiration (In severe pulmonic stenosis, the S2 heart sound is widely split.)", "contents": "Mitral Regurgitation -- History and Physical. Pulmonic stenosis: mid-systolic,\u00a0crescendo-decrescendo murmur, increases in intensity during inspiration (In severe pulmonic stenosis, the S2 heart sound is widely split.)"}
{"id": "article-25198_28", "title": "Mitral Regurgitation -- History and Physical", "content": "Atrial septal defect: mid-systolic murmur with a fixed split S2 heart sound; does not change with\u00a0inspiration", "contents": "Mitral Regurgitation -- History and Physical. Atrial septal defect: mid-systolic murmur with a fixed split S2 heart sound; does not change with\u00a0inspiration"}
{"id": "article-25198_29", "title": "Mitral Regurgitation -- History and Physical", "content": "Hypertrophic\u00a0cardiomyopathy: mid-systolic murmur, heard best medial to the cardiac apex; radiates\u00a0to\u00a0the left sternal border; murmur is louder with Valsalva and standing", "contents": "Mitral Regurgitation -- History and Physical. Hypertrophic\u00a0cardiomyopathy: mid-systolic murmur, heard best medial to the cardiac apex; radiates\u00a0to\u00a0the left sternal border; murmur is louder with Valsalva and standing"}
{"id": "article-25198_30", "title": "Mitral Regurgitation -- History and Physical", "content": "Clinical findings related to MR\u00a0are divided\u00a0into\u00a02\u00a0categories: those related to the MR itself and those associated with the underlying cause. Maintaining a broad differential diagnosis is\u00a0important; with an initially focused history and physical examination, one can establish whether the MR is acute or chronic and thus significantly narrow the possible etiologies.", "contents": "Mitral Regurgitation -- History and Physical. Clinical findings related to MR\u00a0are divided\u00a0into\u00a02\u00a0categories: those related to the MR itself and those associated with the underlying cause. Maintaining a broad differential diagnosis is\u00a0important; with an initially focused history and physical examination, one can establish whether the MR is acute or chronic and thus significantly narrow the possible etiologies."}
{"id": "article-25198_31", "title": "Mitral Regurgitation -- History and Physical -- Acute Mitral Regurgitation", "content": "The clinical assessment of the acute onset of mitral regurgitation will elicit findings associated with a precipitous decline in cardiac output and possibly cardiogenic shock. The patient will usually complain of significant dyspnea at rest, exacerbated in the supine position, as well as cough with clear or pink, frothy sputum. They may also endorse symptoms associated with myocardial ischemia, such as chest pain radiating to the neck, jaw, shoulders, or upper extremities accompanied by nausea and diaphoresis. Physical examination may reveal altered mental status, tachycardia (or bradycardia if there is ischemic involvement of the conduction system), hypotension, tachypnea, hypoxemia, and cyanosis.\u00a0Additionally, jugular venous distension, diffuse crackles on lung auscultation, and an apical holosystolic murmur with radiation to the axilla on a precordial exam may be present.", "contents": "Mitral Regurgitation -- History and Physical -- Acute Mitral Regurgitation. The clinical assessment of the acute onset of mitral regurgitation will elicit findings associated with a precipitous decline in cardiac output and possibly cardiogenic shock. The patient will usually complain of significant dyspnea at rest, exacerbated in the supine position, as well as cough with clear or pink, frothy sputum. They may also endorse symptoms associated with myocardial ischemia, such as chest pain radiating to the neck, jaw, shoulders, or upper extremities accompanied by nausea and diaphoresis. Physical examination may reveal altered mental status, tachycardia (or bradycardia if there is ischemic involvement of the conduction system), hypotension, tachypnea, hypoxemia, and cyanosis.\u00a0Additionally, jugular venous distension, diffuse crackles on lung auscultation, and an apical holosystolic murmur with radiation to the axilla on a precordial exam may be present."}
{"id": "article-25198_32", "title": "Mitral Regurgitation -- History and Physical -- Acute Mitral Regurgitation", "content": "Acute MR is typically related to either papillary muscle rupture from acute coronary syndrome or fulminant destruction of the valvular apparatus secondary to acute bacterial endocarditis. Thus, further clinical assessment should focus on confirming these potentially devastating conditions.", "contents": "Mitral Regurgitation -- History and Physical -- Acute Mitral Regurgitation. Acute MR is typically related to either papillary muscle rupture from acute coronary syndrome or fulminant destruction of the valvular apparatus secondary to acute bacterial endocarditis. Thus, further clinical assessment should focus on confirming these potentially devastating conditions."}
{"id": "article-25198_33", "title": "Mitral Regurgitation -- History and Physical -- Acute Mitral Regurgitation", "content": "In the case of acute bacterial endocarditis, there will be signs and symptoms of sepsis, such as fevers and chills. A history of intravenous drug abuse is highly prevalent, and patients may also have comorbid conditions that predispose them to immunocompromise, such as diabetes mellitus and alcohol use disorder. Due to the embolization of vegetative material, there may be a variety of additional clinical findings depending on the ultimate fate of the emboli. Brain involvement of the emboli will produce focal neurologic deficits; renal involvement will result in hematuria or oliguria; and cutaneous involvement will result in Janeway lesions or widespread petechiae.\u00a0In contrast to subacute bacterial endocarditis, acute infections typically occur in patients with structurally\u00a0normal\u00a0heart valves, and, as such, rheumatic heart disease and prosthetic valves are less common in this population. Furthermore, because the route of bacterial delivery to the mitral valve passes through the right side of the heart, concomitant lesions of the tricuspid and pulmonic valves are not uncommon, and these can often\u00a0be appreciated\u00a0by auscultation of murmurs on physical examination. [27] [30]", "contents": "Mitral Regurgitation -- History and Physical -- Acute Mitral Regurgitation. In the case of acute bacterial endocarditis, there will be signs and symptoms of sepsis, such as fevers and chills. A history of intravenous drug abuse is highly prevalent, and patients may also have comorbid conditions that predispose them to immunocompromise, such as diabetes mellitus and alcohol use disorder. Due to the embolization of vegetative material, there may be a variety of additional clinical findings depending on the ultimate fate of the emboli. Brain involvement of the emboli will produce focal neurologic deficits; renal involvement will result in hematuria or oliguria; and cutaneous involvement will result in Janeway lesions or widespread petechiae.\u00a0In contrast to subacute bacterial endocarditis, acute infections typically occur in patients with structurally\u00a0normal\u00a0heart valves, and, as such, rheumatic heart disease and prosthetic valves are less common in this population. Furthermore, because the route of bacterial delivery to the mitral valve passes through the right side of the heart, concomitant lesions of the tricuspid and pulmonic valves are not uncommon, and these can often\u00a0be appreciated\u00a0by auscultation of murmurs on physical examination. [27] [30]"}
{"id": "article-25198_34", "title": "Mitral Regurgitation -- History and Physical -- Chronic Mitral Regurgitation", "content": "Patients with chronic\u00a0mitral regurgitation\u00a0often remain asymptomatic until late in the course of the disease.\u00a0Clinical findings common to all etiologies include fatigue, dyspnea on exertion, orthopnea, paroxysmal nocturnal dyspnea, dependent edema, weight gain, jugular venous distension, widening of pulse pressure, displaced apical impulse and apical holosystolic murmur with radiation to the axilla. In more advanced cases, there may also be syncope or near syncope, cyanosis, clubbing of digits, hepatomegaly, evidence of ascites with a fluid wave or shifting dullness, gross anasarca, and evidence of pleural or pericardial effusions. These latter findings are reflective of the development of pulmonary hypertension and resultant right ventricular systolic dysfunction from chronic pressure overload. The differential diagnosis is also considerably broader, with specific clinical findings dependent on the etiology. [27]", "contents": "Mitral Regurgitation -- History and Physical -- Chronic Mitral Regurgitation. Patients with chronic\u00a0mitral regurgitation\u00a0often remain asymptomatic until late in the course of the disease.\u00a0Clinical findings common to all etiologies include fatigue, dyspnea on exertion, orthopnea, paroxysmal nocturnal dyspnea, dependent edema, weight gain, jugular venous distension, widening of pulse pressure, displaced apical impulse and apical holosystolic murmur with radiation to the axilla. In more advanced cases, there may also be syncope or near syncope, cyanosis, clubbing of digits, hepatomegaly, evidence of ascites with a fluid wave or shifting dullness, gross anasarca, and evidence of pleural or pericardial effusions. These latter findings are reflective of the development of pulmonary hypertension and resultant right ventricular systolic dysfunction from chronic pressure overload. The differential diagnosis is also considerably broader, with specific clinical findings dependent on the etiology. [27]"}
{"id": "article-25198_35", "title": "Mitral Regurgitation -- Evaluation", "content": "Several tools\u00a0are used\u00a0to evaluate mitral regurgitation; the patient\u2019s history and physical examination should guide the ordering of diagnostic tests.", "contents": "Mitral Regurgitation -- Evaluation. Several tools\u00a0are used\u00a0to evaluate mitral regurgitation; the patient\u2019s history and physical examination should guide the ordering of diagnostic tests."}
{"id": "article-25198_36", "title": "Mitral Regurgitation -- Evaluation -- Echocardiogram", "content": "Echocardiography is the primary and essential diagnostic test for diagnosing and assessing\u00a0mitral regurgitation. [31] Transthoracic echocardiography and transesophageal echocardiography provide qualitative and quantitative analysis.", "contents": "Mitral Regurgitation -- Evaluation -- Echocardiogram. Echocardiography is the primary and essential diagnostic test for diagnosing and assessing\u00a0mitral regurgitation. [31] Transthoracic echocardiography and transesophageal echocardiography provide qualitative and quantitative analysis."}
{"id": "article-25198_37", "title": "Mitral Regurgitation -- Evaluation -- Echocardiogram", "content": "Various methods are available to quantify MR.\u00a0One such method involves measuring the vena contracta, which represents the width of the regurgitant jet as it exits the regurgitant orifice. This provides insight into the regurgitant orifice area (eg,\u00a0vena contracta greater than 7 mm is consistent with severe MR).", "contents": "Mitral Regurgitation -- Evaluation -- Echocardiogram. Various methods are available to quantify MR.\u00a0One such method involves measuring the vena contracta, which represents the width of the regurgitant jet as it exits the regurgitant orifice. This provides insight into the regurgitant orifice area (eg,\u00a0vena contracta greater than 7 mm is consistent with severe MR)."}
{"id": "article-25198_38", "title": "Mitral Regurgitation -- Evaluation -- Echocardiogram", "content": "The Doppler volumetric method is also an option for quantifying MR. This method measures the regurgitant volume\u00a0as the difference between the mitral and aortic stroke volumes.\u00a0Regurgitant volume can\u00a0be calculated\u00a0as the product of effective regurgitant orifice area (EROA) and MR velocity time integral. Severe MR is quantified as: EROA greater than or equal to 0.2 cm 2 Regurgitant volume greater than or equal to 30 mL Regurgitant fraction of 50%\u00a0or higher [32] [33] After the initial echocardiographic evaluation, repeat echocardiography\u00a0is indicated\u00a0for patients with moderate or\u00a0greater\u00a0MR with or without symptoms every: Severe: 6\u00a0to 12 months Moderate: 1\u00a0to 2 years Mild: 3\u00a0to 5 years Repeat echocardiography is also a recommendation for patients with any degree of MR and a change in clinical status or physical examination findings. [31] [34]", "contents": "Mitral Regurgitation -- Evaluation -- Echocardiogram. The Doppler volumetric method is also an option for quantifying MR. This method measures the regurgitant volume\u00a0as the difference between the mitral and aortic stroke volumes.\u00a0Regurgitant volume can\u00a0be calculated\u00a0as the product of effective regurgitant orifice area (EROA) and MR velocity time integral. Severe MR is quantified as: EROA greater than or equal to 0.2 cm 2 Regurgitant volume greater than or equal to 30 mL Regurgitant fraction of 50%\u00a0or higher [32] [33] After the initial echocardiographic evaluation, repeat echocardiography\u00a0is indicated\u00a0for patients with moderate or\u00a0greater\u00a0MR with or without symptoms every: Severe: 6\u00a0to 12 months Moderate: 1\u00a0to 2 years Mild: 3\u00a0to 5 years Repeat echocardiography is also a recommendation for patients with any degree of MR and a change in clinical status or physical examination findings. [31] [34]"}
{"id": "article-25198_39", "title": "Mitral Regurgitation -- Evaluation -- Echocardiogram", "content": "Following MV repair, successful mitigation of MR can\u00a0be quantified\u00a0via several tools.\u00a0One method is measuring tenting height, which is the\u00a0greatest\u00a0mid-systolic distance\u00a0from leaflet\u00a0tips\u00a0to\u00a0the annular\u00a0plane of the mitral valve. The tenting area is defined\u00a0as the area bounded by the mitral annular plane and the anterior and posterior leaflets at mid-systole. In the healthy heart,\u00a0normal\u00a0values are: Tenting height of less than 0.5 cm Tenting\u00a0area of 0 cm 2 Angles of the anterior and posterior mitral leaflet are less than 3 degrees Poor outcomes after\u00a0MV repair\u00a0are defined\u00a0as: Tenting height of greater than or equal to 1 cm Tenting area of greater than 2.5\u00a0to 3 cm 2 Complex jets Posterolateral angle of over 45 degrees [19] [35]", "contents": "Mitral Regurgitation -- Evaluation -- Echocardiogram. Following MV repair, successful mitigation of MR can\u00a0be quantified\u00a0via several tools.\u00a0One method is measuring tenting height, which is the\u00a0greatest\u00a0mid-systolic distance\u00a0from leaflet\u00a0tips\u00a0to\u00a0the annular\u00a0plane of the mitral valve. The tenting area is defined\u00a0as the area bounded by the mitral annular plane and the anterior and posterior leaflets at mid-systole. In the healthy heart,\u00a0normal\u00a0values are: Tenting height of less than 0.5 cm Tenting\u00a0area of 0 cm 2 Angles of the anterior and posterior mitral leaflet are less than 3 degrees Poor outcomes after\u00a0MV repair\u00a0are defined\u00a0as: Tenting height of greater than or equal to 1 cm Tenting area of greater than 2.5\u00a0to 3 cm 2 Complex jets Posterolateral angle of over 45 degrees [19] [35]"}
{"id": "article-25198_40", "title": "Mitral Regurgitation -- Evaluation -- Echocardiogram", "content": "The sphericity index can also quantify the successful mitigation of MR following MV repair. The sphericity index is the ratio between the LV end-diastolic volume and the volume of an imaginary\u00a0sphere, with its diameter extending from the midpoint of the annular\u00a0plane\u00a0to\u00a0the\u00a0apex.\u00a0End-diastolic\u00a0diameter exceeding 65 mm,\u00a0end-systolic diameter over 51 mm, and systolic sphericity index greater than 0.7\u00a0predict\u00a0unfavorable outcomes of MV repair. [35]", "contents": "Mitral Regurgitation -- Evaluation -- Echocardiogram. The sphericity index can also quantify the successful mitigation of MR following MV repair. The sphericity index is the ratio between the LV end-diastolic volume and the volume of an imaginary\u00a0sphere, with its diameter extending from the midpoint of the annular\u00a0plane\u00a0to\u00a0the\u00a0apex.\u00a0End-diastolic\u00a0diameter exceeding 65 mm,\u00a0end-systolic diameter over 51 mm, and systolic sphericity index greater than 0.7\u00a0predict\u00a0unfavorable outcomes of MV repair. [35]"}
{"id": "article-25198_41", "title": "Mitral Regurgitation -- Evaluation -- Echocardiogram", "content": "Successful MV repair can also\u00a0be quantified\u00a0by assessing distance and wall motion. An interpapillary distance\u00a0of over 20 mm, posterior papillary fibrosis distance of more than 40 mm, and lateral wall motion abnormality are associated with poor outcomes after MV repair surgery.", "contents": "Mitral Regurgitation -- Evaluation -- Echocardiogram. Successful MV repair can also\u00a0be quantified\u00a0by assessing distance and wall motion. An interpapillary distance\u00a0of over 20 mm, posterior papillary fibrosis distance of more than 40 mm, and lateral wall motion abnormality are associated with poor outcomes after MV repair surgery."}
{"id": "article-25198_42", "title": "Mitral Regurgitation -- Evaluation -- Electrocardiogram", "content": "Atrial fibrillation is the most common electrocardiogram finding in patients with MR. [27] Patients with atrial fibrillation can also present with more severe MR than patients without arrhythmia. [22]", "contents": "Mitral Regurgitation -- Evaluation -- Electrocardiogram. Atrial fibrillation is the most common electrocardiogram finding in patients with MR. [27] Patients with atrial fibrillation can also present with more severe MR than patients without arrhythmia. [22]"}
{"id": "article-25198_43", "title": "Mitral Regurgitation -- Evaluation -- Chest Radiography", "content": "In patients with chronic MR, cardiomegaly due to left-atrial or right-sided heart enlargement is visible on anterior-posterior x-ray views. [27]", "contents": "Mitral Regurgitation -- Evaluation -- Chest Radiography. In patients with chronic MR, cardiomegaly due to left-atrial or right-sided heart enlargement is visible on anterior-posterior x-ray views. [27]"}
{"id": "article-25198_44", "title": "Mitral Regurgitation -- Evaluation -- Exercise Stress Testing", "content": "In patients with severe, asymptomatic, primary MR, exercise treadmill testing may provide information regarding the patient\u2019s symptom status and exercise tolerance. Exercise echocardiography is\u00a0useful\u00a0to assess changes in MR severity and pulmonary artery pressure in those symptomatic with non-severe MR at rest. [27]", "contents": "Mitral Regurgitation -- Evaluation -- Exercise Stress Testing. In patients with severe, asymptomatic, primary MR, exercise treadmill testing may provide information regarding the patient\u2019s symptom status and exercise tolerance. Exercise echocardiography is\u00a0useful\u00a0to assess changes in MR severity and pulmonary artery pressure in those symptomatic with non-severe MR at rest. [27]"}
{"id": "article-25198_45", "title": "Mitral Regurgitation -- Evaluation -- Cardiac Catheterization", "content": "Cardiac catheterization can\u00a0quantify MR volume with high accuracy when clinical findings are\u00a0inconsistent\u00a0with noninvasive test results.", "contents": "Mitral Regurgitation -- Evaluation -- Cardiac Catheterization. Cardiac catheterization can\u00a0quantify MR volume with high accuracy when clinical findings are\u00a0inconsistent\u00a0with noninvasive test results."}
{"id": "article-25198_46", "title": "Mitral Regurgitation -- Evaluation -- Cardiac Magnetic Resonance Imaging", "content": "Cardiac magnetic resonance imaging (MRI) is an\u00a0important\u00a0and complementary tool to other modalities for assessing the severity of MR. Cardiac MRI accurately assesses quantitative measurements, including regurgitant volume and regurgitant fraction. Cardiac MRI determination of severe MR demonstrates a stronger correlation with left ventricular remodeling (specifically, smaller left ventricular end-diastolic volume following the elimination of MR) than echocardiography. Clinically, cardiac MRI should help differentiate severe from non-severe MR in patients whose echocardiographic evaluation is inconclusive, particularly if contemplating surgery. [36] [37]", "contents": "Mitral Regurgitation -- Evaluation -- Cardiac Magnetic Resonance Imaging. Cardiac magnetic resonance imaging (MRI) is an\u00a0important\u00a0and complementary tool to other modalities for assessing the severity of MR. Cardiac MRI accurately assesses quantitative measurements, including regurgitant volume and regurgitant fraction. Cardiac MRI determination of severe MR demonstrates a stronger correlation with left ventricular remodeling (specifically, smaller left ventricular end-diastolic volume following the elimination of MR) than echocardiography. Clinically, cardiac MRI should help differentiate severe from non-severe MR in patients whose echocardiographic evaluation is inconclusive, particularly if contemplating surgery. [36] [37]"}
{"id": "article-25198_47", "title": "Mitral Regurgitation -- Evaluation -- Biomarkers", "content": "In response to heightened wall stress, ventricular myocytes release the biomarker B-type natriuretic peptide (BNP), which correlates with symptom severity and offers prognostic insights for individuals with MR. A BNP level may be\u00a0normal\u00a0in severe, compensated MR without symptoms or adverse hemodynamic effects. An elevated BNP level is associated with the composite endpoint of the New York Heart Association (NYHA) class III or IV heart failure symptoms, LV dysfunction (ejection fraction less than 60%), or death during follow-up of patients with asymptomatic, severe MR. [38]", "contents": "Mitral Regurgitation -- Evaluation -- Biomarkers. In response to heightened wall stress, ventricular myocytes release the biomarker B-type natriuretic peptide (BNP), which correlates with symptom severity and offers prognostic insights for individuals with MR. A BNP level may be\u00a0normal\u00a0in severe, compensated MR without symptoms or adverse hemodynamic effects. An elevated BNP level is associated with the composite endpoint of the New York Heart Association (NYHA) class III or IV heart failure symptoms, LV dysfunction (ejection fraction less than 60%), or death during follow-up of patients with asymptomatic, severe MR. [38]"}
{"id": "article-25198_48", "title": "Mitral Regurgitation -- Treatment / Management", "content": "The choice of medical versus surgical management of\u00a0mitral regurgitation depends on the condition\u2019s severity, chronicity, comorbidities, and etiology. While some pharmacologic agents can\u00a0be used\u00a0in MR, the evidence for their use is not strong, and they do not have a recommendation from the American College of Cardiology (ACC) or the American Heart Association (AHA). [31] Primary severe MR and ischemic severe MR usually receive treatment with valve surgery. [31] [39]", "contents": "Mitral Regurgitation -- Treatment / Management. The choice of medical versus surgical management of\u00a0mitral regurgitation depends on the condition\u2019s severity, chronicity, comorbidities, and etiology. While some pharmacologic agents can\u00a0be used\u00a0in MR, the evidence for their use is not strong, and they do not have a recommendation from the American College of Cardiology (ACC) or the American Heart Association (AHA). [31] Primary severe MR and ischemic severe MR usually receive treatment with valve surgery. [31] [39]"}
{"id": "article-25198_49", "title": "Mitral Regurgitation -- Treatment / Management -- Medical Management of Mitral Regurgitation", "content": "Angiotensin-converting enzyme inhibitors (ACE) and angiotensin II receptor blockers (ARBs) have been used in those who are asymptomatic to delay the progression of MR. [40] The belief is that ACE inhibitors and ARBs can decrease regurgitant volume and LV size in patients with chronic primary MR. [41] [42] However, there are limited supporting results from studies, and their overall role in treating MR is discouraged. [31] [39] [43] Some study results have concluded no improvement or survival benefit in patients with MR using ACE inhibitors or ARBs and have even shown worsening outcomes for some. [44] [45] In the setting of hypertrophic cardiomyopathy or mitral valve prolapse, vasodilators have demonstrated an increase in the severity of MR. [46]", "contents": "Mitral Regurgitation -- Treatment / Management -- Medical Management of Mitral Regurgitation. Angiotensin-converting enzyme inhibitors (ACE) and angiotensin II receptor blockers (ARBs) have been used in those who are asymptomatic to delay the progression of MR. [40] The belief is that ACE inhibitors and ARBs can decrease regurgitant volume and LV size in patients with chronic primary MR. [41] [42] However, there are limited supporting results from studies, and their overall role in treating MR is discouraged. [31] [39] [43] Some study results have concluded no improvement or survival benefit in patients with MR using ACE inhibitors or ARBs and have even shown worsening outcomes for some. [44] [45] In the setting of hypertrophic cardiomyopathy or mitral valve prolapse, vasodilators have demonstrated an increase in the severity of MR. [46]"}
{"id": "article-25198_50", "title": "Mitral Regurgitation -- Treatment / Management -- Medical Management of Mitral Regurgitation", "content": "Beta-blockers for\u00a0the treatment of MR have also been studied, with results revealing little to no benefit with beta-blocking agents in primary MR; some results have shown increased survival benefit with these agents in secondary MR. [47] One study evaluating the beta blocker\u00a0carvedilol supported\u00a0its use after demonstrating the preservation of LV function, remodeling, and decreased regurgitant volume. [48] The ACC/AHA does not have specific recommendations regarding using beta-blockers in patients with MR. [31]", "contents": "Mitral Regurgitation -- Treatment / Management -- Medical Management of Mitral Regurgitation. Beta-blockers for\u00a0the treatment of MR have also been studied, with results revealing little to no benefit with beta-blocking agents in primary MR; some results have shown increased survival benefit with these agents in secondary MR. [47] One study evaluating the beta blocker\u00a0carvedilol supported\u00a0its use after demonstrating the preservation of LV function, remodeling, and decreased regurgitant volume. [48] The ACC/AHA does not have specific recommendations regarding using beta-blockers in patients with MR. [31]"}
{"id": "article-25198_51", "title": "Mitral Regurgitation -- Treatment / Management -- Medical Management of Mitral Regurgitation", "content": "Loop diuretics\u00a0are believed\u00a0to be helpful in conjunction with other pharmacologic agents to further decrease afterload and regurgitant volume, but further studies are necessary to support this association properly. [41]", "contents": "Mitral Regurgitation -- Treatment / Management -- Medical Management of Mitral Regurgitation. Loop diuretics\u00a0are believed\u00a0to be helpful in conjunction with other pharmacologic agents to further decrease afterload and regurgitant volume, but further studies are necessary to support this association properly. [41]"}
{"id": "article-25198_52", "title": "Mitral Regurgitation -- Treatment / Management -- Surgical\u00a0Management of Mitral Regurgitation", "content": "The decision whether to operate is dependent on the underlying cause of MR. Patients with valvular damage due to chordal or papillary muscle rupture or infective endocarditis require surgery. Patients with functional causes of MR, such as ischemia, generally require coronary artery bypass grafting. [2] [49] Patients with acute, symptomatic MR or an EROA of at least 4 cm 2 require surgical intervention. [28] Surgery for MR is indicated in patients with LV function deterioration or an end-systolic diameter of 45 mm. [50] Patients diagnosed with primary severe MR require surgery when symptomatic with an ejection fraction over 30% or asymptomatic with an EF of 30% to 60%. [51] Mitral valve repair has\u00a02\u00a0aims: An acceptable surface area of mitral valve leaflet coaptation Essential annular dilatation of 5\u00a0to 8 mm [50]", "contents": "Mitral Regurgitation -- Treatment / Management -- Surgical\u00a0Management of Mitral Regurgitation. The decision whether to operate is dependent on the underlying cause of MR. Patients with valvular damage due to chordal or papillary muscle rupture or infective endocarditis require surgery. Patients with functional causes of MR, such as ischemia, generally require coronary artery bypass grafting. [2] [49] Patients with acute, symptomatic MR or an EROA of at least 4 cm 2 require surgical intervention. [28] Surgery for MR is indicated in patients with LV function deterioration or an end-systolic diameter of 45 mm. [50] Patients diagnosed with primary severe MR require surgery when symptomatic with an ejection fraction over 30% or asymptomatic with an EF of 30% to 60%. [51] Mitral valve repair has\u00a02\u00a0aims: An acceptable surface area of mitral valve leaflet coaptation Essential annular dilatation of 5\u00a0to 8 mm [50]"}
{"id": "article-25198_53", "title": "Mitral Regurgitation -- Treatment / Management -- Surgical\u00a0Management of Mitral Regurgitation", "content": "The ACC and AHA generally recommend mitral valve repair over replacement due to decreased recurrence of MR after repair. [31] [52] Available data reveal decreased morbidity and mortality after surgical repair over replacement. [53] However, mitral valve\u00a0replacement is favorable over repair when there is extensive tissue destruction, which can occur in some cases of infective endocarditis. [49] Nevertheless, the newest AHA guidelines clearly state that \u201cmitral valve replacement is preferable to a poor repair.\u201d", "contents": "Mitral Regurgitation -- Treatment / Management -- Surgical\u00a0Management of Mitral Regurgitation. The ACC and AHA generally recommend mitral valve repair over replacement due to decreased recurrence of MR after repair. [31] [52] Available data reveal decreased morbidity and mortality after surgical repair over replacement. [53] However, mitral valve\u00a0replacement is favorable over repair when there is extensive tissue destruction, which can occur in some cases of infective endocarditis. [49] Nevertheless, the newest AHA guidelines clearly state that \u201cmitral valve replacement is preferable to a poor repair.\u201d"}
{"id": "article-25198_54", "title": "Mitral Regurgitation -- Treatment / Management -- Surgical\u00a0Management of Mitral Regurgitation", "content": "With respect to\u00a0surgical replacement of the mitral valve, mechanical prostheses are usually preferable to bioprosthetics due to increased durability and less complicated insertion. Postoperatively, both types require anticoagulation, with bioprosthetic valve replacement requiring only temporary anticoagulation and lifelong anticoagulation with warfarin for mechanical valves. [54]", "contents": "Mitral Regurgitation -- Treatment / Management -- Surgical\u00a0Management of Mitral Regurgitation. With respect to\u00a0surgical replacement of the mitral valve, mechanical prostheses are usually preferable to bioprosthetics due to increased durability and less complicated insertion. Postoperatively, both types require anticoagulation, with bioprosthetic valve replacement requiring only temporary anticoagulation and lifelong anticoagulation with warfarin for mechanical valves. [54]"}
{"id": "article-25198_55", "title": "Mitral Regurgitation -- Treatment / Management -- Surgical\u00a0Management of Mitral Regurgitation", "content": "Mitraclip is another surgical procedure proven to be effective and has low morbidity and mortality in patients considered to be at high risk for repair or replacement. [54] Mitraclip can decrease the mitral valve area, leading to stenosis, and therefore, an area of under 4 cm 2 is a contraindication for this procedure. [55]", "contents": "Mitral Regurgitation -- Treatment / Management -- Surgical\u00a0Management of Mitral Regurgitation. Mitraclip is another surgical procedure proven to be effective and has low morbidity and mortality in patients considered to be at high risk for repair or replacement. [54] Mitraclip can decrease the mitral valve area, leading to stenosis, and therefore, an area of under 4 cm 2 is a contraindication for this procedure. [55]"}
{"id": "article-25198_56", "title": "Mitral Regurgitation -- Differential Diagnosis", "content": "Clinical findings related to MR can be divided into 2 categories: those related to the MR itself and those associated with the underlying cause. Maintaining a broad differential diagnosis is crucial. In general, with an initially focused history and physical examination, one can establish whether the MR is acute or chronic and significantly narrow the possible etiologies that can include the following: Congestive heart failure exacerbation Acute coronary syndrome Hemodynamically unstable dysrhythmia Cardiac tamponade Pneumothorax Pulmonary embolism Septic shock Thyrotoxicosis or thyroid storm The differential diagnosis of chronic mitral regurgitation is also considerably broader, and specific clinical findings depend\u00a0on the etiology.", "contents": "Mitral Regurgitation -- Differential Diagnosis. Clinical findings related to MR can be divided into 2 categories: those related to the MR itself and those associated with the underlying cause. Maintaining a broad differential diagnosis is crucial. In general, with an initially focused history and physical examination, one can establish whether the MR is acute or chronic and significantly narrow the possible etiologies that can include the following: Congestive heart failure exacerbation Acute coronary syndrome Hemodynamically unstable dysrhythmia Cardiac tamponade Pneumothorax Pulmonary embolism Septic shock Thyrotoxicosis or thyroid storm The differential diagnosis of chronic mitral regurgitation is also considerably broader, and specific clinical findings depend\u00a0on the etiology."}
{"id": "article-25198_57", "title": "Mitral Regurgitation -- Staging", "content": "The following staging data for MR is from the 2020 AHA/ACC updated guidelines for\u00a0managing heart valve disease, including mitral regurgitation:", "contents": "Mitral Regurgitation -- Staging. The following staging data for MR is from the 2020 AHA/ACC updated guidelines for\u00a0managing heart valve disease, including mitral regurgitation:"}
{"id": "article-25198_58", "title": "Mitral Regurgitation -- Staging -- Stage A", "content": "At\u00a0risk\u00a0of mitral regurgitation (ie, infective endocarditis, mitral valve prolapse) Normal\u00a0valve leaflets, chords, and annulus in patients with coronary disease or cardiomyopathy Hemodynamics: no MR jet or a small central jet area less than 20% LA on Doppler; small vena contracta less than 3 mm; MR grade can\u00a0be described\u00a0as trace or trivial Cardiac consequences: none or those that are unrelated to the valvular changes Patients at this stage remain asymptomatic [7] [31]", "contents": "Mitral Regurgitation -- Staging -- Stage A. At\u00a0risk\u00a0of mitral regurgitation (ie, infective endocarditis, mitral valve prolapse) Normal\u00a0valve leaflets, chords, and annulus in patients with coronary disease or cardiomyopathy Hemodynamics: no MR jet or a small central jet area less than 20% LA on Doppler; small vena contracta less than 3 mm; MR grade can\u00a0be described\u00a0as trace or trivial Cardiac consequences: none or those that are unrelated to the valvular changes Patients at this stage remain asymptomatic [7] [31]"}
{"id": "article-25198_59", "title": "Mitral Regurgitation -- Staging -- Stage B", "content": "Progressive mitral regurgitation occurs in this stage. ECG assessment of mitral valve anatomy demonstrates mild tethering of mitral leaflets and annular dilation with a normal to slight loss of central coaptation that may be associated with prior infective endocarditis (IE.) Hemodynamics: EROA is less than 0.4 cm2, regurgitant volume below 60 mL, and regurgitant fraction below 50%. There might be a central regurgitant jet that is only 20% to 40% in magnitude or a late systolic eccentric jet. The venta contracta should not exceed 7 mm in width in all cases. MR grade is 1+ to 2+. Cardiac consequences:\u00a0Left atrial enlargement begins at this stage. Left ventricular dimensions and pulmonary pressures are usually not affected. Patients at this stage remain asymptomatic.", "contents": "Mitral Regurgitation -- Staging -- Stage B. Progressive mitral regurgitation occurs in this stage. ECG assessment of mitral valve anatomy demonstrates mild tethering of mitral leaflets and annular dilation with a normal to slight loss of central coaptation that may be associated with prior infective endocarditis (IE.) Hemodynamics: EROA is less than 0.4 cm2, regurgitant volume below 60 mL, and regurgitant fraction below 50%. There might be a central regurgitant jet that is only 20% to 40% in magnitude or a late systolic eccentric jet. The venta contracta should not exceed 7 mm in width in all cases. MR grade is 1+ to 2+. Cardiac consequences:\u00a0Left atrial enlargement begins at this stage. Left ventricular dimensions and pulmonary pressures are usually not affected. Patients at this stage remain asymptomatic."}
{"id": "article-25198_60", "title": "Mitral Regurgitation -- Staging -- Stage C", "content": "Asymptomatic severe mitral regurgitation occurs in this stage.", "contents": "Mitral Regurgitation -- Staging -- Stage C. Asymptomatic severe mitral regurgitation occurs in this stage."}
{"id": "article-25198_61", "title": "Mitral Regurgitation -- Staging -- Stage C", "content": "ECG assessment of mitral valve anatomy shows a flail leaflet or severe mitral valve prolapse (MVP) and loss of central coaptation due to leaflet restriction. Causes can be prior IE or a history of chest irradiation.", "contents": "Mitral Regurgitation -- Staging -- Stage C. ECG assessment of mitral valve anatomy shows a flail leaflet or severe mitral valve prolapse (MVP) and loss of central coaptation due to leaflet restriction. Causes can be prior IE or a history of chest irradiation."}
{"id": "article-25198_62", "title": "Mitral Regurgitation -- Staging -- Stage C", "content": "Hemodynamics: EROA is greater than or equal to 0.4 cm2, regurgitant volume is greater than or equal to 60 mL, regurgitant fraction is greater than or equal to 50%, central regurgitant jet that is greater than 40%, or there is a pansystolic eccentric jet. MR grade is 2+ to 3+.", "contents": "Mitral Regurgitation -- Staging -- Stage C. Hemodynamics: EROA is greater than or equal to 0.4 cm2, regurgitant volume is greater than or equal to 60 mL, regurgitant fraction is greater than or equal to 50%, central regurgitant jet that is greater than 40%, or there is a pansystolic eccentric jet. MR grade is 2+ to 3+."}
{"id": "article-25198_63", "title": "Mitral Regurgitation -- Staging -- Stage C", "content": "Cardiac consequences: patients at this stage\u00a0are categorized\u00a0as C1 (preserved ejection fraction greater than\u00a060%, LV end-systolic diameter is less than 40 mm, or C2 (reduced ejection fraction\u00a0less than or equal to 60% or LV end-systolic diameter is\u00a0greater\u00a0than 40 mm). Both categories exhibit moderate to severe LA enlargement with some LV distension.", "contents": "Mitral Regurgitation -- Staging -- Stage C. Cardiac consequences: patients at this stage\u00a0are categorized\u00a0as C1 (preserved ejection fraction greater than\u00a060%, LV end-systolic diameter is less than 40 mm, or C2 (reduced ejection fraction\u00a0less than or equal to 60% or LV end-systolic diameter is\u00a0greater\u00a0than 40 mm). Both categories exhibit moderate to severe LA enlargement with some LV distension."}
{"id": "article-25198_64", "title": "Mitral Regurgitation -- Staging -- Stage C", "content": "Patients at this stage remain\u00a0largely\u00a0asymptomatic. Some patients may experience symptoms upon severe physical exertion.", "contents": "Mitral Regurgitation -- Staging -- Stage C. Patients at this stage remain\u00a0largely\u00a0asymptomatic. Some patients may experience symptoms upon severe physical exertion."}
{"id": "article-25198_65", "title": "Mitral Regurgitation -- Staging -- Stage D", "content": "Symptomatic severe mitral regurgitation defines this stage. ECG assessment of mitral valve anatomy is similar to stage C with increased severity and extent. Hemodynamics:\u00a0EROA is\u00a0greater\u00a0than 0.4 cm 2 ,\u00a0regurgitant volume greater than or equal to 60 mL, regurgitant\u00a0fraction greater than or equal to 50%, vena contracta\u00a0greater than or equal to 7 mm, central regurgitant jet that is greater than 40%, or a pansystolic eccentric jet. MR grade is 3+ to 4+. Cardiac changes as described in grade C with evidence of pulmonary hypertension Heart failure symptoms due to mitral regurgitation persist even after revascularization and optimization of medical therapy, decreased exercise tolerance, and exertional dyspnea.", "contents": "Mitral Regurgitation -- Staging -- Stage D. Symptomatic severe mitral regurgitation defines this stage. ECG assessment of mitral valve anatomy is similar to stage C with increased severity and extent. Hemodynamics:\u00a0EROA is\u00a0greater\u00a0than 0.4 cm 2 ,\u00a0regurgitant volume greater than or equal to 60 mL, regurgitant\u00a0fraction greater than or equal to 50%, vena contracta\u00a0greater than or equal to 7 mm, central regurgitant jet that is greater than 40%, or a pansystolic eccentric jet. MR grade is 3+ to 4+. Cardiac changes as described in grade C with evidence of pulmonary hypertension Heart failure symptoms due to mitral regurgitation persist even after revascularization and optimization of medical therapy, decreased exercise tolerance, and exertional dyspnea."}
{"id": "article-25198_66", "title": "Mitral Regurgitation -- Prognosis", "content": "Mitral regurgitation is a common\u00a0yet debilitating condition that leads to increased morbidity and mortality, and research is valuable for finding new techniques for managing this condition. [56] Mitral valve repair and replacement surgeries have been extensively studied and have shown significant improvement in symptoms and mortality. Several pertinent studies follow:", "contents": "Mitral Regurgitation -- Prognosis. Mitral regurgitation is a common\u00a0yet debilitating condition that leads to increased morbidity and mortality, and research is valuable for finding new techniques for managing this condition. [56] Mitral valve repair and replacement surgeries have been extensively studied and have shown significant improvement in symptoms and mortality. Several pertinent studies follow:"}
{"id": "article-25198_67", "title": "Mitral Regurgitation -- Prognosis", "content": "A study of 144 patients with mitral regurgitation found that the 5-year mortality was a remarkable 30% compared to 13% of the age-matched control group. The study also determined that patients with functional mitral regurgitation had an overall increase in morbidity and mortality than those with structural MR. [57]", "contents": "Mitral Regurgitation -- Prognosis. A study of 144 patients with mitral regurgitation found that the 5-year mortality was a remarkable 30% compared to 13% of the age-matched control group. The study also determined that patients with functional mitral regurgitation had an overall increase in morbidity and mortality than those with structural MR. [57]"}
{"id": "article-25198_68", "title": "Mitral Regurgitation -- Prognosis", "content": "Another study of patients 50 and older with medical treatment alone for mitral regurgitation calculated a yearly mortality rate for moderate and severe organic mitral regurgitation as 3% and 6%, respectively. [6]", "contents": "Mitral Regurgitation -- Prognosis. Another study of patients 50 and older with medical treatment alone for mitral regurgitation calculated a yearly mortality rate for moderate and severe organic mitral regurgitation as 3% and 6%, respectively. [6]"}
{"id": "article-25198_69", "title": "Mitral Regurgitation -- Prognosis", "content": "A study of 83 patients (asymptomatic, mean age of 56, and undergoing early mitral valve surgery) found residual mitral regurgitation requiring re-repair in 1%, and 4% required a permanent pacemaker. The 10-year survival rate after surgery was 91.5%. [58]", "contents": "Mitral Regurgitation -- Prognosis. A study of 83 patients (asymptomatic, mean age of 56, and undergoing early mitral valve surgery) found residual mitral regurgitation requiring re-repair in 1%, and 4% required a permanent pacemaker. The 10-year survival rate after surgery was 91.5%. [58]"}
{"id": "article-25198_70", "title": "Mitral Regurgitation -- Prognosis", "content": "Patients with degenerative or rheumatic heart disease and a mean age of 57 years undergoing mitral valve repair had comparable survival rates with individuals in the general population. A study of 125 mitral valve repairs determined postoperative early mortality in 2.4% of the patients and a 10-year survival rate of 84.3%. [59]", "contents": "Mitral Regurgitation -- Prognosis. Patients with degenerative or rheumatic heart disease and a mean age of 57 years undergoing mitral valve repair had comparable survival rates with individuals in the general population. A study of 125 mitral valve repairs determined postoperative early mortality in 2.4% of the patients and a 10-year survival rate of 84.3%. [59]"}
{"id": "article-25198_71", "title": "Mitral Regurgitation -- Prognosis", "content": "A\u00a0systematic review and meta-analysis\u00a0of patients with severe MR with a reduced ejection fraction (under 40%) compared mitral valve repair surgery versus mitral valve replacement surgery regarding operative mortality. In one study of patients undergoing mitral valve repair, the operative mortality\u00a0was determined\u00a0to be 5%. However, the mortality rate following mitral valve replacement was estimated to be 10%. [53]", "contents": "Mitral Regurgitation -- Prognosis. A\u00a0systematic review and meta-analysis\u00a0of patients with severe MR with a reduced ejection fraction (under 40%) compared mitral valve repair surgery versus mitral valve replacement surgery regarding operative mortality. In one study of patients undergoing mitral valve repair, the operative mortality\u00a0was determined\u00a0to be 5%. However, the mortality rate following mitral valve replacement was estimated to be 10%. [53]"}
{"id": "article-25198_72", "title": "Mitral Regurgitation -- Prognosis", "content": "The\u00a0greatest\u00a0predictor of survival and improvement of symptoms after\u00a0MV surgery was shown to be a pre-operative ejection fraction over 60%. [60] Mitral valve repair is associated with increased survival and decreased morbidity and mortality compared to mitral valve replacement. [54] [61]", "contents": "Mitral Regurgitation -- Prognosis. The\u00a0greatest\u00a0predictor of survival and improvement of symptoms after\u00a0MV surgery was shown to be a pre-operative ejection fraction over 60%. [60] Mitral valve repair is associated with increased survival and decreased morbidity and mortality compared to mitral valve replacement. [54] [61]"}
{"id": "article-25198_73", "title": "Mitral Regurgitation -- Complications", "content": "Complications of mitral regurgitation include: Heart failure and related symptoms (ie, shortness of breath) Atrial fibrillation Stroke due to arrhythmias Pulmonary artery hypertension Dilation of the heart and cardiomegaly Complications of mitral valve surgery or replacement include: Infections (including infective endocarditis) Bleeding Clotting and stenosis of new valve Valve dysfunction Arrhythmias Stroke Death", "contents": "Mitral Regurgitation -- Complications. Complications of mitral regurgitation include: Heart failure and related symptoms (ie, shortness of breath) Atrial fibrillation Stroke due to arrhythmias Pulmonary artery hypertension Dilation of the heart and cardiomegaly Complications of mitral valve surgery or replacement include: Infections (including infective endocarditis) Bleeding Clotting and stenosis of new valve Valve dysfunction Arrhythmias Stroke Death"}
{"id": "article-25198_74", "title": "Mitral Regurgitation -- Postoperative and Rehabilitation Care", "content": "Most patients can\u00a0be discharged\u00a0postoperatively if no complications (ie, infection or bleeding) arise during the procedure or hospitalization. Postoperative guidelines have undergone study, and the following are the recommendations: A postoperative ECG should be performed soon after the procedure before discharge and is periodically necessary to assess left ventricular function, especially if symptoms arise. Lifelong anticoagulation, typically with warfarin, is indicated for mechanical or prosthetic valve replacements. Clinicians should initiate antibiotic prophylaxis for infective endocarditis before dental, oral, or upper respiratory tract procedures in patients with a mechanical or prosthetic valve or a history of endocarditis. [27] [62] [63]", "contents": "Mitral Regurgitation -- Postoperative and Rehabilitation Care. Most patients can\u00a0be discharged\u00a0postoperatively if no complications (ie, infection or bleeding) arise during the procedure or hospitalization. Postoperative guidelines have undergone study, and the following are the recommendations: A postoperative ECG should be performed soon after the procedure before discharge and is periodically necessary to assess left ventricular function, especially if symptoms arise. Lifelong anticoagulation, typically with warfarin, is indicated for mechanical or prosthetic valve replacements. Clinicians should initiate antibiotic prophylaxis for infective endocarditis before dental, oral, or upper respiratory tract procedures in patients with a mechanical or prosthetic valve or a history of endocarditis. [27] [62] [63]"}
{"id": "article-25198_75", "title": "Mitral Regurgitation -- Postoperative and Rehabilitation Care", "content": "Exercise therapy and cardiac rehabilitation after heart valve surgery have been extensively studied and\u00a0are generally recommended. Some data\u00a0supports improved exercise\u00a0capacity\u00a0and ejection fraction; however, further studies\u00a0are needed\u00a0to develop a definite\u00a0correlation. [64] [65] [66] [67]", "contents": "Mitral Regurgitation -- Postoperative and Rehabilitation Care. Exercise therapy and cardiac rehabilitation after heart valve surgery have been extensively studied and\u00a0are generally recommended. Some data\u00a0supports improved exercise\u00a0capacity\u00a0and ejection fraction; however, further studies\u00a0are needed\u00a0to develop a definite\u00a0correlation. [64] [65] [66] [67]"}
{"id": "article-25198_76", "title": "Mitral Regurgitation -- Postoperative and Rehabilitation Care", "content": "In a retrospective study of 105 patients who underwent heart valve surgery, the mean time\u00a0for them to return to work was about\u00a05\u00a0months.\u00a0These patients also showed improved ejection fraction, with 78.4% of patients studied categorized in NYHA stage I or II compared with 38.1% before heart valve\u00a0surgery. [68]", "contents": "Mitral Regurgitation -- Postoperative and Rehabilitation Care. In a retrospective study of 105 patients who underwent heart valve surgery, the mean time\u00a0for them to return to work was about\u00a05\u00a0months.\u00a0These patients also showed improved ejection fraction, with 78.4% of patients studied categorized in NYHA stage I or II compared with 38.1% before heart valve\u00a0surgery. [68]"}
{"id": "article-25198_77", "title": "Mitral Regurgitation -- Consultations", "content": "A cardiologist is necessary for the diagnosis and medical management of MR, and a cardiothoracic surgeon consult would be necessary if surgery is indicated.", "contents": "Mitral Regurgitation -- Consultations. A cardiologist is necessary for the diagnosis and medical management of MR, and a cardiothoracic surgeon consult would be necessary if surgery is indicated."}
{"id": "article-25198_78", "title": "Mitral Regurgitation -- Deterrence and Patient Education", "content": "Patients could benefit from understanding the symptoms indicative of severe MR and recognizing when to seek medical assistance. Additionally, it is valuable for patients with MR to understand the criteria for surgery and available treatment options. While patients diagnosed with moderate or severe secondary mitral regurgitation may benefit from surgery, with an improvement in symptoms and quality of life, there has been no proven survival benefit from surgery. In most cases, it is not indicated or performed. [31]", "contents": "Mitral Regurgitation -- Deterrence and Patient Education. Patients could benefit from understanding the symptoms indicative of severe MR and recognizing when to seek medical assistance. Additionally, it is valuable for patients with MR to understand the criteria for surgery and available treatment options. While patients diagnosed with moderate or severe secondary mitral regurgitation may benefit from surgery, with an improvement in symptoms and quality of life, there has been no proven survival benefit from surgery. In most cases, it is not indicated or performed. [31]"}
{"id": "article-25198_79", "title": "Mitral Regurgitation -- Deterrence and Patient Education", "content": "In the older adult population (eg, 60+), study results have shown that surgeons opt not to perform this surgery due to\u00a0no\u00a0survival\u00a0benefit.\u00a0Several factors affect treatment decisions. In a study of 1741 patients with mitral regurgitation, only 60.31% received surgical treatment. This number decreased to 54.71% in the age group\u00a0greater\u00a0than 60. [69] In another study of 396 patients diagnosed with severe mitral regurgitation, 49%\u00a0were not operated\u00a0on due to comorbid conditions. [70] Surgical decision-making should consider impaired left-ventricular ejection fraction, older age, and comorbid conditions. Consult with a cardiologist regarding\u00a0the management of\u00a0mitral regurgitation, as patient treatment options can vary depending on several factors.", "contents": "Mitral Regurgitation -- Deterrence and Patient Education. In the older adult population (eg, 60+), study results have shown that surgeons opt not to perform this surgery due to\u00a0no\u00a0survival\u00a0benefit.\u00a0Several factors affect treatment decisions. In a study of 1741 patients with mitral regurgitation, only 60.31% received surgical treatment. This number decreased to 54.71% in the age group\u00a0greater\u00a0than 60. [69] In another study of 396 patients diagnosed with severe mitral regurgitation, 49%\u00a0were not operated\u00a0on due to comorbid conditions. [70] Surgical decision-making should consider impaired left-ventricular ejection fraction, older age, and comorbid conditions. Consult with a cardiologist regarding\u00a0the management of\u00a0mitral regurgitation, as patient treatment options can vary depending on several factors."}
{"id": "article-25198_80", "title": "Mitral Regurgitation -- Enhancing Healthcare Team Outcomes", "content": "Mitral valve regurgitation\u00a0is an increasingly common valvular heart disease associated with a wide range of causes and symptoms. Due to comorbidities, MR has a significant mortality rate, especially in the population older than 60, and the only definitive treatment is surgery. [6] MR is universally under-diagnosed and under-treated, leading to its increased prevalence. [56] The ACC and AHA have developed evidence-based guidelines for evaluating, diagnosing, and managing valvular diseases. [31]", "contents": "Mitral Regurgitation -- Enhancing Healthcare Team Outcomes. Mitral valve regurgitation\u00a0is an increasingly common valvular heart disease associated with a wide range of causes and symptoms. Due to comorbidities, MR has a significant mortality rate, especially in the population older than 60, and the only definitive treatment is surgery. [6] MR is universally under-diagnosed and under-treated, leading to its increased prevalence. [56] The ACC and AHA have developed evidence-based guidelines for evaluating, diagnosing, and managing valvular diseases. [31]"}
{"id": "article-25198_81", "title": "Mitral Regurgitation -- Enhancing Healthcare Team Outcomes", "content": "Interprofessional healthcare team members should recognize that early diagnosis and management have proven to be lifesaving, and advancements in medicine and valvular studies have contributed to a significant decrease in morbidity and mortality of this disease. Developing a team of specialized healthcare professionals, such as cardiologists and cardiac surgeons, has significantly improved patient\u00a0care due to efficiency and efficacy in managing the patient and the decision-making process. [71]", "contents": "Mitral Regurgitation -- Enhancing Healthcare Team Outcomes. Interprofessional healthcare team members should recognize that early diagnosis and management have proven to be lifesaving, and advancements in medicine and valvular studies have contributed to a significant decrease in morbidity and mortality of this disease. Developing a team of specialized healthcare professionals, such as cardiologists and cardiac surgeons, has significantly improved patient\u00a0care due to efficiency and efficacy in managing the patient and the decision-making process. [71]"}
{"id": "article-25198_82", "title": "Mitral Regurgitation -- Enhancing Healthcare Team Outcomes", "content": "Nurses trained in cardiology monitor patients, provide education, and facilitate team communication, reporting all observations to the appropriate clinical staff. Pharmacists review the dosing and potential interactions of medications\u00a0and educate patients and the healthcare team. Patient care does not end in the operating room; postoperative care and cardiac rehabilitation require a team of healthcare professionals who are crucial for improved patient outcomes and morale.", "contents": "Mitral Regurgitation -- Enhancing Healthcare Team Outcomes. Nurses trained in cardiology monitor patients, provide education, and facilitate team communication, reporting all observations to the appropriate clinical staff. Pharmacists review the dosing and potential interactions of medications\u00a0and educate patients and the healthcare team. Patient care does not end in the operating room; postoperative care and cardiac rehabilitation require a team of healthcare professionals who are crucial for improved patient outcomes and morale."}
{"id": "article-25198_83", "title": "Mitral Regurgitation -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Mitral Regurgitation -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}